Credit: ARS Pharmaceuticals. Intranasal epinephrine was found to be absorbed quicker. The New Drug Application (NDA) for neffy ®, an intranasal formulation of epinephrine, has been accepted for review ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 16, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results